introduction
play

Introduction of an Adequate Saphenous Vein Lack of usable GSV is - PowerPoint PPT Presentation

Bypass Surgery Options in the Absence Introduction of an Adequate Saphenous Vein Lack of usable GSV is common: 20-40% Matthew T. Menard, M.D . Re-operative lower extremity bypass Brigham and Womens Hospital Prior CABG, vein


  1. Bypass Surgery Options in the Absence Introduction of an Adequate Saphenous Vein • Lack of usable GSV is common: 20-40% Matthew T. Menard, M.D . • Re-operative lower extremity bypass Brigham and Women’s Hospital • Prior CABG, vein stripping Harvard Medical School PREVENT III PREVENT III Conduit Type Vein Graft Size Schanzer, JVS 2007 Schanzer, JVS 2007 1

  2. PREVENT III General Strategies High vs Low Risk Conduit • Perform the best, most durable procedure possible. • Use the best available autogenous vein. Schanzer, JVS 2007 Options Re-operative Survey: Challenges • Contralateral Greater Saphenous Vein • Arm Vein • Vascular bad actors: Intimal hyperplasia, • Lesser Saphenous Vein sclerotic veins, hypercoagulable states, etc • Scarring • Cryopreserved vein • More advanced disease. • Prosthetic grafts • Endovascular/hybrid 2

  3. CLV Harvest and Fate of the Contralateral GSV Contralateral Limb • Only 16% needed intervention in contra leg • 12% bypass • 4% amputation JVS 2002 3

  4. Infrainguinal Bypass in the Absence of GSV: Arm Vein Lesser Saphenous Vein Disadvantages: Advantages: • Same operative field. • Can be tenuous quality • Can be qualitatively similar to GSV. » Antecubital scarring » Focal phlebitis, sclerosis Disadvantages: » Short vein segments. • Tedious exposure. • Unreliable quality. • Tedious harvest of basilic/brachial vein • Short vein segments. • Prone to twisting Composite Vein Grafts: Demographics (Chew 1998) • 154 patients • Limb salvage in 90% • Redo: 48% 4

  5. Number of Segments Patency of Composite Grafts 110 100 90 LS 79% + 5% % Cumulative Patency 80 SP 65% + 5% 70 3 Seg 60 50 PP 44% + 5% 23% 2 Seg 40 75% 30 20 10 4 Seg 0 0 10 20 30 40 50 60 70 2% Time (months) Composite Vein Grafts Chew, JVS, 2001 5

  6. Patency Rates Prosthetic Grafts 90 Cumulative Patency (%) 80 70 Primary Patency Rate 60 50 Primary Assisted Patency Rate 40 30 Secondary Patency Rate 20 10 0 1 4 7 10 13 16 19 22 Months P=ns, Log-rank test Summary of meta-analysis data since 1981 Distaflo Grafts carbon lined engineered cuffs 6

  7. Distaflo Grafts 7

  8. Propaten: Thromboresistant lumenal graft surface Linton patch Heparin Bonded PTFE • Italian, 7 center, retrospective review • 425 bypass for CLI (101 AK, 324 BK) • 36 month results: PP 61%, SP 70% • No diff AK vs BK Pulli et al, JVS, 2010;51:1167 8

  9. Miller cuff St. Mary’s boot Tyrell MR, Wolfe JHN; Br J Surg 1991 Tyrell MR, Wolfe JHN; Br J Surg 1991 9

  10. Tyrell MR, Wolfe JHN; Br J Surg 1991 Tyrell MR, Wolfe JHN; Br J Surg 1991 Tyrell MR, Wolfe JHN; Br J Surg 1991 Tyrell MR, Wolfe JHN; Br J Surg 1991 10

  11. Dardik H, et al J Vasc Surg 1996 Taylor patch Secondary Patency Alternative Vein Prosthetic 100 90 80 70 % Patency 68.8% 60 68.4% 50 P=0.488 40 30 20 Number at risk 10 33 25 21 AV 17 12 10 0 52 34 25 Pros 14 9 8 0 12 24 36 48 60 Months 11

  12. Summary • Do the best operation/procedure you can • Use the best vein available. • Prosthetic is reasonable option, and is better than bad vein • Need for appropriate creativity in hybrid era 12

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend